Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837

Jaco A C van Bruggen^{1

2

3

4

5}, Anne W J Martens^{1

2

3

4

5}, Sanne H Tonino^{1

3

4

5}, Arnon P Kater^{1

3

4

5}

Affiliations

¹ Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
² Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
³ Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
⁴ Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.
⁵ Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands.

Published Erratum

Jaco A C van Bruggen et al. Cancers (Basel). 2021.

. 2021 Sep 22;13(19):4738.

doi: 10.3390/cancers13194738.

Jaco A C van Bruggen^{1

2

3

4

5}, Anne W J Martens^{1

2

3

4

5}, Sanne H Tonino^{1

3

4

5}, Arnon P Kater^{1

3

4

5}

¹ Department of Hematology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
² Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
³ Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.
⁴ Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, The Netherlands.
⁵ Lymphoma and Myeloma Center Amsterdam, LYMMCARE, 1105 AZ Amsterdam, The Netherlands.

Abstract

In the original article [...].

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma.
van Bruggen JAC, Martens AWJ, Tonino SH, Kater AP. van Bruggen JAC, et al. Cancers (Basel). 2020 Dec 18;12(12):3837. doi: 10.3390/cancers12123837. Cancers (Basel). 2020. PMID: 33353234 Free PMC article. Review.

1. van Bruggen J.A.C., Martens A.W.J., Tonino S.H., Kater A.P. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers. 2020;12:3837. doi: 10.3390/cancers12123837. - DOI - PMC - PubMed